Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From a sore throat to the intensive care unit: the Lemierre syndrome.
Hochmair M, Valipour A, Oschatz E, Hollaus P, Huber M, Chris Burghuber O. Hochmair M, et al. Among authors: valipour a. Wien Klin Wochenschr. 2006 May;118(7-8):243-6. doi: 10.1007/s00508-006-0571-8. Wien Klin Wochenschr. 2006. PMID: 16794763 Clinical Trial.
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution.
Hochmair M, Weinlinger C, Schwab S, Naber J, Setinek U, Krenbek D, Urban MH, Fabikan H, Watzka S, Koger R, Fazekas A, Bitterlich E, Valipour A, Burghuber OC. Hochmair M, et al. Among authors: valipour a. Anticancer Drugs. 2019 Aug;30(7):e0787. doi: 10.1097/CAD.0000000000000787. Anticancer Drugs. 2019. PMID: 31305295 Clinical Trial.
Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
Hochmair MJ, Setinek U, Krenbek D, Fazekas A, Illini O, Weinlinger C, Draxler H, Marcher M, Valipour A, Müllauer L, Beer L. Hochmair MJ, et al. Among authors: valipour a. Clin Lung Cancer. 2020 Mar;21(2):e49-e53. doi: 10.1016/j.cllc.2019.11.010. Epub 2019 Nov 20. Clin Lung Cancer. 2020. PMID: 31879191 No abstract available.
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
Hochmair MJ, Fabikan H, Illini O, Weinlinger C, Setinek U, Krenbek D, Prosch H, Rauter M, Schumacher M, Wöll E, Wass R, Brehm E, Absenger G, Bundalo T, Errhalt P, Urban M, Valipour A. Hochmair MJ, et al. Among authors: valipour a. Pharmaceuticals (Basel). 2020 Nov 7;13(11):371. doi: 10.3390/ph13110371. Pharmaceuticals (Basel). 2020. PMID: 33171712 Free PMC article.
Organizing pneumonia following Covid19 pneumonia.
Funk GC, Nell C, Pokieser W, Thaler B, Rainer G, Valipour A. Funk GC, et al. Among authors: valipour a. Wien Klin Wochenschr. 2021 Sep;133(17-18):979-982. doi: 10.1007/s00508-021-01852-9. Epub 2021 Apr 16. Wien Klin Wochenschr. 2021. PMID: 33861398 Free PMC article.
193 results